Androgen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the α subunit of the translation initiation factor 2.
The type I transmembrane protein with epidermal growth factor and two follistatin motifs 2 (TMEFF2), is expressed mainly in brain and prostate. Expression of TMEFF2 is deregulated in prostate cancer, suggesting a role in this disease, but the molecular mechanism(s) involved in this effect are not cl...
Main Authors: | Ryan F Overcash, Vesna A Chappell, Thomas Green, Christopher B Geyer, Adam S Asch, Maria J Ruiz-Echevarría |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3566213?pdf=render |
Similar Items
-
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer
by: Constantin Georgescu, et al.
Published: (2019-05-01) -
TMEFF2 inhibits pancreatic cancer cells proliferation, migration, and invasion by suppressing phosphorylation of the MAPK signaling pathway
by: Han H, et al.
Published: (2019-12-01) -
Tmeff2 is expressed in differentiating oligodendrocytes but dispensable for their differentiation in vivo
by: Hao Huang, et al.
Published: (2017-03-01) -
TMEFF2 promoter hypermethylation is an unfavorable prognostic marker in gliomas
by: Sidi Xie, et al.
Published: (2021-03-01) -
TMEFF2: A Transmembrane Proteoglycan with Multifaceted Actions in Cancer and Disease
by: Motasim Masood, et al.
Published: (2020-12-01)